Dr. Amir Ali Talasaz
Senior Director of Scientific Research, Illumina
January 24, 2012 | 12:00 to 01:00 | 540 Cory Hall, DOP Center Conference Room
Host: Michel Maharbiz
Next-gen nucleic acid analysis is paving the way for a new era in healthcare and personalized medicine. Through introduction of new genome analysis technologies, the cost reduction of nucleic acid analysis has outpaced Moore’s Law. The current price points have already facilitated the translation of few genomic tests such as prenatal diagnostics into medical care. However, more technology advancements are needed to increase adoption of sequencing in clinical practice. In this talk, I will present Illumina’s sequencing technology and our efforts developing a fast desktop sequencer with simplified user workflow suitable for clinical settings. I will then discuss new sample preparation technologies for analyzing single cell genomics. The power of these tools has been demonstrated in purification and sequencing of single circulating tumor cells in peripheral blood of cancer patients. This work has generated new biological insight into cancer metastasis and has tremendous potential in enhancing personalized cancer management.
Interested in nominating someone to speak at the BSAC Technology Seminar? We welcome you to submit a speaker nomination here